期刊文献+

稳定表达流感病毒基质蛋白2的哺乳动物细胞系的建立 被引量:2

Establishment of Mammalian Cell Lines for Constitutive Expression of Influenza Virus Matrix Protein 2
原文传递
导出
摘要 本研究构建了稳定表达甲型流感病毒基质蛋白2(M2)的哺乳动物细胞系。应用PCR方法扩增A/PR/8/34(H1N1)株流感病毒M2基因,将其克隆至真核表达载体pcDNA5/FRT(pDF)上,构建出pDF-M2重组质粒。将鉴定正确的pDF-M2与表达Flp重组酶的pOG44质粒共转染Flp-In-CHO细胞,通过体内同源重组使目的基因整合到宿主细胞染色体上。筛选具有Hygromycin B抗性的重组细胞株命名为CHO-M2。以间接免疫荧光法(IFA)和Western blot法检测M2的表达,共获得15株高表达M2蛋白的重组细胞株。这些重组细胞株在连续培养10代后,PCR方法仍可检测到M2基因的存在,IFA也检测到蛋白的稳定表达。本研究成功获得了稳定表达甲型流感病毒M2的哺乳动物细胞系,为M2蛋白的功能研究和非复制型流感病毒疫苗的研制提供了新的工具。 To establish a mammalian celI line for stable expression of the matrix protein 2 (M2) of influenza virus type A. M2 gene was amplified by PCR from the influenza virus strain A/PR/8/34. The PCR prod- uct was cloned into eukaryotic expression vector pcDNAS/FRT. After identification with restriction enzyme digestion, the plasmid was co-transfected with plasmid pOG44 which expressed Flp in Flp-In-CHO cells. The target gene was integrated into chromosome of CHO cells by homologous recombination in vivo. Recombinant CHO-M2 cell lines were selected for hygromycin B resistance. A total of 15 recombinant cell strains with high expression of M2 protein were screened by hygromycin, and the expression of M2 protein was determined by IFA and Western blot. After subculturing for l0 passages, the presence of M2 gene in the CHO-M2 cells was confirmed by PCR, and the expression of M2 protein were proved by IFA and Western blot. We successfully constructed a mammalian cell line which stably expressed M2 protein of in- fluenza virus type A. The cell line will be useful for studies on function of M2 protein and provide tools for novel influenza virus vaccine development.
出处 《病毒学报》 CAS CSCD 北大核心 2013年第1期7-11,共5页 Chinese Journal of Virology
基金 传染病防治科技重大专项(编号:2009ZX10004-710)
关键词 基质蛋白2 流感病毒 哺乳动物细胞系 Matrix protein 2 Influenza virus Mammalian cell line
  • 相关文献

参考文献12

  • 1刘晓宇,郭建强,姚立红,陈爱珺,付金奇,张智清.可调控表达甲型流感病毒M2蛋白的哺乳动物细胞系的建立与鉴定[J].生物工程学报,2011,27(5):747-754. 被引量:5
  • 2万春和,刘明.A型流感病毒M2蛋白研究进展[J].动物医学进展,2007,28(7):56-60. 被引量:4
  • 3X Xu,H Nagarajan,NE Lewis,S Pan,Z Cai,X Liu,W Chen,M Xie,W Wang,S Hammond,MR Andersen,N Neff,B Passarelli,W Koh,HC Fan,J Wang,Y Gui,KH Lee,MJ Betenbaugh,SR Quake,I Famili,BO Palsson,J Wang.The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line[].Nature Biotechnology.2011
  • 4Steel J,Lowen AC,Pena L,Angel M,Solorzano A,Albrecht R,Perez DR,Garcia-Sastre A,Palese P.Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza[].Journal of Virology.2009
  • 5Schotsaert M,De Filette M,Fiers W,et al.Universal M2ectodomain-based influenza A vaccines:preclinical andclinical developments[].Expert Review of Vaccines.2009
  • 6Jefferson T,Demicheli V,Rivetti D,et al.Antivirals for in-fluenza in healthy adults:systematic review[].The Lancet.2006
  • 7Watanahe S,Watanabe T,Kawaoka Y.Influenza A virus lacking M2Protein as a live attenuated vaccine[].Journal of Virology.2009
  • 8Song H,Nieto GR,Perez DR.A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates[].Journal of Virology.2007
  • 9Solorzano A,Ye J,Perez D R.Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu.[].Journal of Virology.2010
  • 10M. F. McCown,A. Pekosz.The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging[].Journal of Virology.2005

二级参考文献36

  • 1郑丽舒,段招军.A型流感病毒M2蛋白疫苗的研究进展[J].病毒学报,2006,22(6):488-491. 被引量:1
  • 2姜建波,提金凤,李志杰.新型疫苗研究概况[J].动物医学进展,2007,28(1):96-100. 被引量:4
  • 3程小雯,郭元吉.流行性感冒病毒及其实验技术.北京:中国三峡出版社,1997:28.
  • 4Schotsaert M, De Filette M, Fiers W, et al. Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Expert Rev Vaccines, 2009, 8(4): 499-508.
  • 5Feng JQ, Zhang MX, Mozdzanowska K, et al. Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2. Virol J, 2006, 3: 102-114.
  • 6Mozdzanowska K, Zharikova D, Cudic M, et al. Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse. Virol J, 2007,4: 118-131.
  • 7De Filette M, Martens W, Roose K, et al. An influenza A vaccine based on tetrameric ectodomain of matrix protein 2. J Biol Chem, 2008, 283(17): 11382-11387.
  • 8Song HC, Nieto GR, Perez DR. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. J Virol, 2007, 81(17): 9238 9248.
  • 9Solorzano A, Ye JQ, Perez DR. Alternative live-attenuated influenza vaccines based on modifications in the polymerase genes protect against epidemic and pandemic flu. J Virol, 2010, 84(9): 4587-4596.
  • 10Steel J, Lowen AC, Pena L, et al. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol, 2009, 83(4): 1742-1753,.

共引文献7

同被引文献18

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部